fda stopping tirzepatide ban on compounded tirzepatide: Switch to name brand medications F.D.A. Approves New Obesity Drug

She has worked through diet and intense exercise to manage her weight

Donnelly JE, Blair SN, Jakicic JM, et al

But theyre not identical medications

Week-by-week nutrition adjustments as your dose increases Your dietary approach should evolve as your semaglutide dose increases through the standard titration schedule

After discontinuing its internal GLP-1 in May of 2025 for causing liver issues, Pfizer won a bidding war against seven other companies for Metsera, which is developing a variety of incretin assets, paying $10 billion in one of 2025s largest M&A deals

This transparent model eliminates hidden markups, where costs might be artificially inflated before being passed to the plan sponsor, and removes the incentive for PBMs to prioritize higher-cost drugs